Ph I Oral Topotecan and Temozolomide for Patients With Malignant Gliomas
NCT00610571
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
62
Enrollment
OTHER
Sponsor class
Conditions
Glioblastoma
Gliosarcoma
Anaplastic Astrocytoma
Interventions
DRUG:
Oral Topotecan and Temodar
Sponsor
Katy Peters
Collaborators
[object Object]
[object Object]